1. Home
  2. BOLT vs PETZ Comparison

BOLT vs PETZ Comparison

Compare BOLT & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$3.99

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Logo TDH Holdings Inc.

PETZ

TDH Holdings Inc.

N/A

Current Price

$1.30

Market Cap

11.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BOLT
PETZ
Founded
2015
2002
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
11.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
BOLT
PETZ
Price
$3.99
$1.30
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
29.4K
71.8K
Earning Date
05-13-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,695,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$133.33
N/A
P/E Ratio
N/A
$6.89
Revenue Growth
0.07
N/A
52 Week Low
$3.75
$0.81
52 Week High
$7.20
$1.83

Technical Indicators

Market Signals
Indicator
BOLT
PETZ
Relative Strength Index (RSI) 39.33 46.57
Support Level N/A $0.99
Resistance Level $5.05 $1.35
Average True Range (ATR) 0.39 0.14
MACD -0.04 -0.03
Stochastic Oscillator 17.50 2.40

Price Performance

Historical Comparison
BOLT
PETZ

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About PETZ TDH Holdings Inc.

TDH Holdings Inc currently focus on commercial real estate management. The company has determined that it has only one operating segment which is commercial real estate leasing operations. The company has presence in China and United States of which majority of revenue comes from China.

Share on Social Networks: